Clinical Trials
10 trialsNCT04720157 2026-05-27
PSMAddition
Novartis
Phase 3 Active not recruiting
NCT05849298 2026-05-27
PSMACare
Novartis
Phase 2 Active not recruiting
NCT06574880 2026-05-26
STARLiT
Case Comprehensive Cancer Center
Phase 1/2 Recruiting
NCT05682443 2026-05-22
PRESERVE-006
OncoC4, Inc.
Phase 1/2 Active not recruiting
NCT07587814 2026-05-14
COCORIVO
Centre Henri Becquerel
Phase NA Not yet recruiting
NCT07226986 2026-05-11
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Novartis
Phase 1/2 Recruiting
NCT05114746 2026-05-08
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan
Novartis
Phase 2 Completed
NCT06632977 2026-05-08
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT06852820 2026-05-08
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
Case Comprehensive Cancer Center
Phase 2 Recruiting
NCT07025512 2026-05-08
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
M.D. Anderson Cancer Center
Phase 2 Withdrawn